More than 300 completely new medicines, vaccines and treatments for more than 150 conditions have entered the U.S. market since 1990, with a raft of benefits for consumers. The need for many surgeries has been reduced; survival rates are higher; quality of life has improved. Indeed, between 1986 and 2000, the average life expectancy for Americans and others around the world increased by a full two years, and a big chunk of that gain — roughly 40 percent — comes from pharmaceuticals, according to the Pharmaceutical Research and Manufacturers of America.
Loading ...
The Med-Tech Industry’s Relentless Pursuit of Cures – and Cash
Posted by: Katherine Noyes November 3, 2007 01:30 AMMore than 300 completely new medicines, vaccines and treatments for more than 150 conditions have entered the U.S. market since 1990, with a raft of benefits for consumers. The need for many surgeries has been reduced; survival rates are higher; quality of life has improved. Indeed, between 1986 and 2000, the average life expectancy for Americans and others around the world increased by a full two years, and a big chunk of that gain — roughly 40 percent — comes from pharmaceuticals, according to the Pharmaceutical Research and Manufacturers of America.